Avalyn Pharma Inc
About
Leadership
Board of Directors
Investors
Timeline
Therapeutic Focus
Overview
Inhaled Advantage
Publications
Pipeline
Overview
AP01
AP02
AP02-DP
AP03
AP04
AP0X
Patients
Overview
Expanded Access
News & Events
News
Events
Careers
Overview
Open Positions
Contact
With family history of IPF, Founder Mark Surber conceives of inhaled pirfenidone (AP01)
MENU
About
Leadership
Board of Directors
Investors
Timeline
Therapeutic Focus
Overview
Inhaled Advantage
Publications
Pipeline
Overview
AP01
AP02
AP02-DP
AP03
AP04
AP0X
Patients
Overview
Expanded Access
News & Events
News
Events
Careers
Overview
Open Positions
Contact